Latest Impairment News

Amotiv Limited reports a slight decline in EBITA for FY25 alongside a significant non-cash impairment on its APG business, reflecting a cautious outlook amid challenging market conditions.

Perpetual Limited reported a 2.5% increase in assets under management to A$226.8 billion for Q4 FY25, driven by strong market performance and inflows. The company reaffirmed its expense guidance and continues to pursue the sale of its Wealth Management business.

Papyrus Australia has fully impaired its investments in its Egyptian joint ventures PPYEg and EBFC, citing lack of returns and governance issues ahead of its 2025 audited results.

South32 has exceeded its FY25 production targets, driven by a 20% increase in copper output and significant progress at its Hermosa project, while streamlining its portfolio through key divestments.

McPherson’s Limited anticipates FY25 revenue around $139 million with a strong second-half EBITDA rebound, while its strategic shift to third-party wholesalers sets the stage for significant EBIT gains in FY26.

Marimaca Copper Corp. has issued a prospectus for a nominal cleansing offer of 100 new CDIs at A$10.65 each, aiming to remove trading restrictions on previously issued securities. The company also disclosed extensive risk factors, including ongoing legal proceedings and project development uncertainties.

South32 warns of an impending impairment expense linked to uncertain electricity supply for its Mozal Aluminium smelter, with FY26 production guidance now under review amid ongoing tariff negotiations.

Jatcorp anticipates a significant net loss for FY2025 driven by halted sales in China and legal disputes, yet remains cautiously optimistic about growth prospects in FY2026.

ECS Botanics is supplying its Avani THC10 capsules to a University of Western Australia clinical trial exploring medicinal cannabis as a treatment for obstructive sleep apnoea. The study aims to shed light on THC’s impact on sleep quality and cognitive function.

Tourism Holdings Limited trims its FY25 profit guidance to the lower end of analyst expectations, citing ongoing challenges in global RV sales and a potential goodwill impairment tied to its US operations.

Collins Foods Limited has confirmed its FY25 earnings aligned closely with market forecasts, addressing ASX concerns over potential surprises. The company highlighted positive margin outcomes and clarified the impact of a Netherlands impairment.

Brickworks Limited reports a mixed second half of FY25 with strong property gains offset by a significant impairment in its North American operations, while its planned merger with Soul Patts remains on track.